Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Adverum Biotechnologies Inc. (ADVM)

9.53   0.4 (4.38%) 11-19 12:25
Open: 9.21 Pre. Close: 9.13
High: 9.575 Low: 9.02
Volume: 374,771 Market Cap: 616M
Adverum Biotechnologies Inc is a gene therapy company committed to discovering and developing novel medicines that can offer potentially life-changing therapeutic benefit to patients living with rare diseases or diseases of the eye.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 9.412 - 9.458 9.458 - 9.496
Low: 8.785 - 8.847 8.847 - 8.896
Close: 9.043 - 9.137 9.137 - 9.213

Technical analysis

as of: 2019-11-19 11:55:35 AM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 11.17     One year: 13.05
Support: Support1: 7.50    Support2: 6.23
Resistance: Resistance1: 9.56    Resistance2: 11.17
Pivot: 8.44
Moving Average: MA(5): 9.22     MA(20): 8.12
MA(100): 9.80     MA(250): 7.36
MACD: MACD(12,26): 0.63     Signal(9): 0.48
Stochastic oscillator: %K(14,3): 96.31     %D(3): 93.30
RSI: RSI(14): 68.78
52-week: High: 16.38  Low: 2.81  Change(%): 163.8
Average Vol(K): 3-Month: 203159  10-Days: 90183

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
ADVM has closed below upper band by 14.1%. Bollinger Bands are 26.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Stock Analysts’ Upgrades for November, 12th (ACAD, ADVM, AOBC, ATSG, BIDU, CLLS, DXPE, FEYE, FHB, FSBW)
Stock Analysts’ upgrades for Tuesday, November 12th: ACADIA Pharmaceuticals (NASDAQ:ACAD) was upgraded by analysts at BidaskClub from a sell rating to a hold rating. Adverum Biotechnologies (NASDAQ:ADVM) was upgraded by analysts at BidaskClub from a hold rating to a buy rating. American Outdoor Brands (NASDAQ:AOBC) was upgraded by analysts at BidaskClub from a buy rating […]

Adverum Biotechnologies Enters Oversold Territory
Adverum Biotechnologies has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 64.59
Shares Float (M) 36.69
% Held by Insiders 11.22
% Held by Institutions 73.40
Shares Short (K) 9740
Shares Short P. Month (K)

Stock Financials

EPS -0.960
Book Value (p.s.) 2.540
PEG Ratio
Profit Margin
Operating Margin -18703.44
Return on Assets (ttm) -17.3
Return on Equity (ttm) -32.2
Qtrly Rev. Growth -70.0
Gross Profit (p.s.) -0.751
Sales Per Share
EBITDA (p.s.) -0.902
Qtrly Earnings Growth
Operating Cash Flow (M) -47.06
Levered Free Cash Flow (M) -34.67

Stock Valuations

P/E -9.95
P/E Growth Ratio 0.05
P/BV 3.76
P/CF -13.11

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.